ROC Reports Mixed Q1 2026 Results Amid Government Contract Delays
Event summary
- ROC reported Q1 2026 revenue of $2.5M, down 20% YoY due to government contract delays from the late-2025 shutdown.
- Product revenue declined slightly to $2.3M, but ROC Watch and ROC ABIS grew 77% and 255% YoY respectively.
- Government R&D contract revenue dropped 69% YoY to $0.2M, impacted by procurement timing and funding constraints.
- ROC completed its IPO in February 2026, raising $21.5M and listing on the Nasdaq Capital Market.
- The company expanded its product lineup with ROC Access Face1, awarded 'Best in Biometrics' at ISC West 2026.
The big picture
ROC's Q1 2026 results highlight the volatility of government contracting, a key revenue driver for the company. The 20% YoY revenue decline underscores the impact of procurement delays, but strong growth in ROC Watch and ROC ABIS signals robust demand for Vision AI solutions. The company's strategic focus on expanding its product portfolio and scaling deployments positions it to capitalize on the increasing convergence of identity, video intelligence, and digital evidence markets.
What we're watching
- Government Contract Recovery
- Whether ROC can rebound from government contract delays as procurement activity ramps up in Q2 and Q3.
- Product Commercialization
- The pace at which ROC can convert early adoption of ROC ABIS and ROC Access into sustainable revenue growth.
- Operational Scaling
- How ROC will deploy its $21.5M IPO proceeds to support larger, longer-duration program deployments.
Related topics
